Introduction
============

The early stage diagnosis of renal cell carcinoma (RCC) in many countries is probably associated with the observed plateau in RCC mortality in the US and in many European countries. Nevertheless, \~50% of patients diagnosed across all stages of this disease die within the first 5 years after diagnosis.[@b1-ott-9-1327],[@b2-ott-9-1327] Conventional chemotherapy and radiotherapy does not exert a significant long-term benefit on RCC; instead, it has been found to decrease the length or quality of life. RCC is not a single disease; rather, it is a compilation of several types of cancer that occur in the kidney. The poor prognosis of RCC is largely due to the effects of different oncogenes, each having a different histology and response to therapy.[@b3-ott-9-1327] Metabolic control analysis is useful in assessing the influence of metabolic pathways on the course and treatment of complex diseases.[@b4-ott-9-1327],[@b5-ott-9-1327] Since the metabolic environment influences the rate-controlling steps of enzymes in metabolic pathways, the management of complex disease phenotypes is largely dependent on the expression of the entire collection of genes involved than on any particular gene or enzyme.[@b6-ott-9-1327],[@b7-ott-9-1327] This means that the management of complex disease phenotypes relies on a collection of system-wide interconnected processes that involve glycolysis and respiration. Successful manipulations of metabolic networks can lead to restoration of order and adaptive behavior in disordered states that involve complex gene--environment interactions.[@b8-ott-9-1327],[@b9-ott-9-1327]

Metabolic control analysis is especially important in kidney cancer management, because disorder and abnormal energy metabolism are characteristics of RCC.[@b10-ott-9-1327] However, there are few specific studies that identify the tumor-related metabolic proteins in RCC. In the present study, a comprehensive bioinformatics approach was applied to tissue proteomic data to identify those metabolic steps and networks that have a role in RCC onset and development. In kidney cancer, the expression of proteins involved in metabolism, cell growth, morphology, and the heat shock response is deregulated. Therefore, we hypothesize that the defects in identified pathways should serve as targets for the development of effective and long-lasting kidney cancer therapies that will be superior to those presently in use.

Materials and methods
=====================

Tissue samples
--------------

Surgical specimens of five patients from the Navy General Hospital, obtained after radical nephrectomy, were used to prepare tissue samples of conventional RCC and the surrounding noncancerous kidney tissues. The mean age of the patients was 55.8 years. The tumor stage of the patients ranged from pT1 to pT3. Macroscopic cell type of samples (benign or cancer) was examined histologically. The tumor stage was determined according to the 1997 TNM (tumor, node, metastasis) criteria. The samples were not necrotic. [Table 1](#t1-ott-9-1327){ref-type="table"} shows a summary of detailed clinicopathologic data of patients included in the study. Institutional Ethics Committee of the Navy General Hospital approved this project, and informed consent were obtained from all patients, or their relatives, prior to commencing the study. A pathologist examined all specimens. The samples were immediately frozen in liquid nitrogen and stored at −80°C until use.

2-DE and image analysis
-----------------------

Two-dimensional electrophoresis (2-DE) was performed as described previously.[@b11-ott-9-1327] Briefly, cells were lysed in the lysis buffer (8 M urea, 2 M thiourea, 4% CHAPS, 100 mM DTT, and 0.2% pH 3--10 ampholyte; Bio-Rad Laboratories Inc., Hercules, CA, USA) containing a protease inhibitor. After sonication and centrifugation, the supernatant was retrieved, and protein concentrations were determined using the DC protein assay kit (Bio-Rad Laboratories Inc.). Protein samples (1 mg) were applied to a immobilized pH gradient strip (17 cm, pH 3--10 non-linear \[NL\], Bio-Rad Laboratories Inc.) using a passive rehydration method. For the second dimension, a 30 mA constant current was applied to 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis gel after isoelectric focusing and equilibration. The gels were stained using CBB R-250 (EMD Millipore, Billerica, MA, USA) and scanned with a Bio-Rad GS-800 scanner (Bio-Rad Laboratories Inc.). The 2-DE analyses were independently repeated three times. The maps were analyzed by PDQuest software, Version 6.1 (Bio-Rad Laboratories Inc.). The quantity of each spot in the gel was normalized as the percentage of the total quantity of all spots in that gel and evaluated in terms of optical density (OD). The paired *t*-test was performed to compare the data from three repeated experiments. Only those spots that showed consistent and significant differences (\>1.5-fold, *P*\<0.05) were selected for further analysis with mass spectra (MS).

In-gel digestion
----------------

In-gel digestion of proteins was performed using mass spectrometry grade Trypsin Gold (Promega Corporation, Madison, WI, USA). Briefly, the spots were cut out of the gel (1--2 mm diameter) using a razor blade and destained twice with 100 mM NH~4~HCO~3~/50% acetonitrile (ACN) at 37°C for 45 minutes in each treatment. After drying, the gels were preincubated in 10--20 μL trypsin solution for 1 hour. Following, 15 μL digestion buffer was added (40 mM NH~4~HCO~3~/10% ACN) to cover each gel and incubated overnight at 37°C. Tryptic digests were extracted using Milli-Q water initially, followed by two 1 hour repeat extractions with 50% ACN/5% trifluoroacetic acid. The combined extracts were dried in a vacuum concentrator at room temperature. The samples were then subjected to mass spectrometric analysis.

MS/MS analysis and protein identification
-----------------------------------------

Mass spectra were acquired using a quadrupole time-of-flight mass spectrometer (Micromass, Manchester, UK) fitted with an electrospray ionization or matrix-assisted laser desorption/ionization source (Micromass). The MS/MS analysis was performed as described previously.[@b12-ott-9-1327] The MS/MS data were acquired and processed using MassLynx V 4.1 software (Micromass) and converted to PKL performed using ProteinLynx 2.2.5 software (Waters Corp, Milford, MA, USA). The pkl files were analyzed using the MASCOT search engine (<http://www.matrixscience.com>). The following search parameters were used: database, Swiss-Prot, taxonomy, *Homo sapiens*, enzyme, and trypsin. One missed cleavage was allowed. Carbamidomethylation was selected as a fixed modification, and oxidation of methionine was set as the variable. The peptide and fragment mass tolerance were set at 0.1 Da and 0.05 Da, respectively. Positively identified proteins had at least one peptide exceeding their score threshold (*P*\<0.05), and their molecular weight and isoelectric point consistent with the gel regions from which the spots were excised. The spectra of proteins identified by a single peptide, and with a score \>40 (lower were discarded) were manually inspected.

Immunoblot
----------

The radioimmunoprecipitation assay lysis buffer (50 mM Tris-HCl \[pH 7.4\], 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1 mg/mL aprotinin, 1 mM Na~3~VO~4~, and 1 mM NaF) was used to break open the cells. The proteins were then suspended in the Lammli sample buffer and centrifuged at 15,000 rpm for 30 minutes. The supernatant was recovered for analysis. Each protein sample of 10 μg was loaded per well and separated with 12.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis. The proteins inside the gel were electroblotted onto polyvinylidene fluoride membranes (EMD Millipore) by wet blotting. After incubation in the blocking buffer (1× Tris-buffered saline, 0.1% Tween-20, and 5% w/v dry nonfat milk) for 1 hour at room temperature, the membranes were incubated by primary antibodies. Following, the membrane were incubated with secondary antibodies for 45 minutes at room temperature. Enhanced chemiluminescence was used to detect reactive bands (Amersham Biosciences Corp, Piscataway, NJ, USA).

Bioinformatics and statistical analysis
---------------------------------------

Gene Ontology search was used to ([www.geneontology.org](http://www.geneontology.org)) classify and determine the functions of identified proteins. Pathway data were obtained from the Kyoto Encyclopedia of Genes and Genomes (<http://www.genome.jp/kegg>) -- a collection of online databases dealing with genomes, enzymatic pathways, and biological chemicals.[@b13-ott-9-1327] Protein--protein interactions were identified with the search tool STRING database. Both direct (physical) and indirect (functional) protein associations were examined.[@b14-ott-9-1327],[@b15-ott-9-1327]

The two-tailed Student's *t*-test was used to determine the significant differences between the control and the exposure groups. Statistical analysis was performed using SPSS 16.0 software (SPSS Inc., Chicago, IL, USA), and *P*\<0.05 was considered statistically significant.

Results
=======

2-DE profiling of differentially expressed proteins
---------------------------------------------------

Protein expression in RCC tissues and the corresponding normal kidney tissues was examined by 2-DE. [Figure 2](#f2-ott-9-1327){ref-type="fig"} shows a pair of representative 2-DE maps. Proteins extracted from RCC tissues and the corresponding normal kidney tissues was resolved by 2-DE and visualized by CBB R-250 staining. Those protein spots with a *P*-value \<0.05 according to the Student's *t*-test and reproducible changes in intensity \>1.5-fold were identified. The analysis resulted in a total of 90 protein spots that were differentially expressed between RCC tissues and the corresponding normal kidney tissues; of those, 73 proteins were successfully identified by MS/MS ([Table 2](#t2-ott-9-1327){ref-type="table"}). Twenty-six proteins were downregulated and 47 proteins were upregulated in RCC tissues ([Figures 1](#f1-ott-9-1327){ref-type="fig"} and [2](#f2-ott-9-1327){ref-type="fig"}).

Protein identification and functional classification
----------------------------------------------------

Seventy-three proteins were identified ([Figure 1](#f1-ott-9-1327){ref-type="fig"}) and are listed [Table 2](#t2-ott-9-1327){ref-type="table"}. The MS/MS data, which included the mass and intensity values, and the charge of the precursor ions, were compared against the SWISS-PROT protein database using a licensed copy of the MASCOT 2.0 program. [Figure 3](#f3-ott-9-1327){ref-type="fig"} shows a representative MS/MS map of spot \#9. Among them, HIBCH was downregulated in RCC tissues in comparison with the adjacent nonmalignant tissues (*P*\<0.05). Furthermore, MS/MS analysis revealed 12 matching peptides, with 44% sequence coverage and a MOWSE score of 714 ([Figure 3](#f3-ott-9-1327){ref-type="fig"}).

Immunoblotting validation for differentially expressed proteins
---------------------------------------------------------------

Two altered proteins, EIF5A and PKM2, were further validated by Western blotting. As shown in [Figure 4](#f4-ott-9-1327){ref-type="fig"}, EIF5A and PKM2 were upregulated in RCC tissue in comparison with adjacent nonmalignant tissue, which was consistent with the 2-DE results (*P*\<0.05).

Network, pathway, and process analyses of significantly changed proteins
------------------------------------------------------------------------

[Table 2](#t2-ott-9-1327){ref-type="table"} lists differentially expressed proteins in RCC and the corresponding normal tissues, as confirmed by mass spectrometry. Their molecular function and biological processes are included in [Table 2](#t2-ott-9-1327){ref-type="table"}. Interactions exist among these proteins, and most of them are a part of a biological network, as illustrated by STRING ([Figure 5](#f5-ott-9-1327){ref-type="fig"}). Out of 73 identified proteins, 63 were interconnected and ten proteins did not show any type of connection at the selected confidence level (STRING score =0.4). The following significant functions are associated with this network of proteins: metabolism, transcription, proteolysis, electron transport, and molecular chaperoning. ENO1, ENO2, AKR1A1, PGAM1, and PGA are important proteins in gluconeogenesis, while PSME2, PSMA3, PSMB4, and PSMB8 are involved in proteasome-related proteolysis. The proteins were divided into several classes as a result of bioinformatic analysis based on the Kyoto Encyclopedia of Genes and Genomes pathway, which included: gluconeogenesis, the urea cycle and amino acid metabolism, proteasome, fatty acid metabolism, glutathione (GSH) metabolism, and so forth ([Table 3](#t3-ott-9-1327){ref-type="table"}).

Discussion
==========

Identifying the changes in protein expression in cancer cells is a useful predictor of potential changes in the functional pathways, which are, in turn, directly related to the basic mechanism of cancer onset and progression. Analysis at the proteome level enables the identification of proteins that are differentially expressed in RCC and adjacent normal tissues. These RCC-specific protein biomarkers might facilitate more efficient subclassification and early diagnosis of RCC.[@b16-ott-9-1327],[@b17-ott-9-1327] In this study, we analyzed the expression of proteins in eleven pairs of RCC tissues and matching normal kidney tissues from RCC patients utilizing two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. We found that 47 proteins were overexpressed and 26 proteins underexpressed in RCC. An altered expression of some of these proteins has previously been observed in RCC.[@b18-ott-9-1327] The analysis of biochemical pathways conducted in this study has led to identification of protein networks, which play important roles in oncogenesis or progression of clear cell RCC (ccRCC).

The finding that glycolysis enzyme levels are most significantly altered in ccRCC is in accordance with the results of other independent studies conducted in different types of cancers.[@b19-ott-9-1327]--[@b21-ott-9-1327] Increased aerobic glycolysis in cancer, a phenomenon known as the Warburg effect, is characterized by increased metabolism of glucose to lactate in the presence of sufficient oxygen. There is a strong connection between this effect and malignant transformation, as evidenced from studies conducted on various tumor cells.[@b22-ott-9-1327]--[@b24-ott-9-1327] p53 and c-myc are considered to be the key tumor genes and the master regulators of metabolism.[@b25-ott-9-1327],[@b26-ott-9-1327] The pyruvate kinase (PK) gene, which encodes a protein that converts phosphoenolpyruvate to pyruvate with release of an adenosine triphosphate, is the target gene of Myc and HIF-1.[@b27-ott-9-1327] The dimeric form of M2-PK is another protein specific for tumor cells (known as tumor M2-PK), the dimerization seems to be caused by the interaction of M2-PK with certain oncoproteins. It is believed that this adaptive mechanism allows tumor cells to survive in environments where the levels of oxygen and nutrients are not constant.[@b28-ott-9-1327] The interconversion of glycerate-3-phosphate and glycerate-2-phosphate is catalyzed by the glycolytic enzyme phosphoglycerate mutase, while enolase catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. The expression of enolase is regulated both developmentally and specifically within the tissues. Proteome analysis reported in a recent study has shown that both phosphoglycerate mutase and enolase seem to be differentially overexpressed in human lung squamous carcinoma. Our data suggest that anaerobic glycolysis-related enzyme PK, enolase, is upregulated, whereas the other carbohydrate metabolism-related enzymes, phosphoenolpyruvate carboxy kinase (PCK2) and acetyl-CoA acetyltransferase (ACAT1), are downregulated in RCC, which is consistent with the results from other laboratories.[@b29-ott-9-1327],[@b30-ott-9-1327] Recently, the role of agents targeting glycolytic activity and glycolysis-linked metabolic processes is being studied for reversal of Warburg effect.[@b31-ott-9-1327],[@b32-ott-9-1327] Proteasomes and ubiquitin (Ub) are key participants of the energy-dependent, nonlysosomal proteolytic pathway. Previous studies have indicated that cell proliferation and apoptosis are regulated by the Ub--proteasome system. The research community is focusing its efforts on identifying the potential role of certain proteasome inhibitors to act as novel anticancer agents.[@b33-ott-9-1327] In this work, Ubiquitin-40S ribosomal protein S27a and four members of the proteasome family, PSME2, PSMA3, PSMB4, and PSMB8 were highly expressed in RCC, which is consistent with one previous study.[@b34-ott-9-1327] Other studies have suggested that proteasomes and Ub also have important roles in various nonproteolytic functions. Proteasomes are thought to regulate the translational activities of cytoplasmic mRNAs.[@b35-ott-9-1327] Ub has been found to have many apparently distinct roles, such as DNA repair, cell cycle progression, modification of polypeptide receptors, and biogenesis of ribosomes.[@b36-ott-9-1327],[@b37-ott-9-1327]

GSH has multiple roles in the body; it is involved in cell differentiation, proliferation, and apoptosis, as well as antioxidant defense and nutrient metabolism.[@b38-ott-9-1327] It has been shown that enzymes involved in GSH metabolism, particularly glutathione *S*-transferase and glutathione peroxidase, play a role in multistage carcinogenesis.[@b39-ott-9-1327] Our results point to significant variations in the GSH-dependent enzyme activity in RCC and support the finding that GSH metabolism is important in RCC onset and progression. Because they have high energy demands, cancer cells are forced to tap into alternative sources of energy, such as fatty acid oxidation and other nonglycolytic pathways. Our findings suggest that the products of fatty acid metabolism have a key role in RCC metabolism. Fatty acid-binding proteins (FABPs) are involved in lipid metabolism, regulation of gene expression, cell signaling, cell growth, and differentiation.[@b40-ott-9-1327] Moreover, FABPs also have an important role in carcinogenesis.[@b41-ott-9-1327] Studies identifying FABP as tumor markers of RCC emphasize the significant role of fatty acid metabolism in the biology of RCC.[@b42-ott-9-1327],[@b43-ott-9-1327] In comparison with normal tissues, we found that liver-type FABP was expressed at lower rates in 53% of all tumors, which is consistent with the findings from other studies.[@b44-ott-9-1327]

The results of this study indicate that other pathways closely associated with gluconeogenesis, such as the urea cycle, pyruvate, pentanoate, and butanoate metabolism, as well as arginine and proline metabolism, are downregulated in ccRCC. In contrast, an increase in one of the key glycolytic enzymes, pyruvate, was observed.

Our study outlines the metabolic phenotype of RCC tissue in detail. Using proteomic analysis to determine which pathways and processes are likely involved in kidney cancer, we found that the glycolysis pathway is significantly altered in ccRCC. Alterations to these pathways will allow clinicians to identify those molecules that affect metabolic regulation, such as activators or inhibitors of HIF-1, mTOR, and AMP kinase, as well as assess the effectiveness of therapy at the molecular level.
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![Representative 2-DE gel images of RCC tissue compared to adjacent nonmalignant tissue.\
**Notes:** The gels were stained with Coomassie brilliant blue R250. Differentially expressed protein spots were labeled with numbers.\
**Abbreviations:** RCC, renal cell carcinoma; 2-DE, two-dimensional electrophoresis.](ott-9-1327Fig1){#f1-ott-9-1327}

![The enlargement of six selected regions as examples of protein spots that are dysregulated in this study.\
**Notes:** Protein spot discrepancies were labeled with arrows and marked with numbers (to the left of the images).](ott-9-1327Fig2){#f2-ott-9-1327}

![Identification of protein spot \#9.\
**Notes:** (**A**) Peptide mass fingerprinting (PMF) of protein HIBCH. (**B**) HIBCH was identified by searching the MS/MS database using the MASCOT program. The matching peptides are shown in bold red.\
**Abbreviations:** HIBCH, 3-Hydroxyisobutyryl-CoA Hydrolase; MS, mass spectra.](ott-9-1327Fig3){#f3-ott-9-1327}

![Western bolt detection of EIF5A and PKM2 expression in RCC tissue (T) and adjacent non-malignant tissue (N).\
**Notes:** (**A**) EIF5A and PKM2 were upregulated in RCC tissue. (**B**) Western blot data were quantified densitometrically and β-actin was used as the loading control. Data are expressed as mean ± SD from three independent experiments. \**P*\<0.05, compared with adjacent non-malignant tissue.\
**Abbreviation:** RCC, renal cell carcinoma.](ott-9-1327Fig4){#f4-ott-9-1327}

![Signaling networks/functional analysis of dysregulated proteins in RCC.\
**Notes:** The identified differentially expressed proteins were analyzed using the STRING tool.[@b14-ott-9-1327] In this map, the network nodes represent proteins. The edges represent predicted functional associations. An edge may be drawn with several different lines. These lines represent the existence of several types of evidence used in predicting the associations.\
**Abbreviation:** RCC, renal cell carcinoma.](ott-9-1327Fig5){#f5-ott-9-1327}

###### 

Clinicopathologic features of renal cell carcinoma samples

  No   Sex      Age (years)   Clinicopathologic features        TNM stage
  ---- -------- ------------- --------------------------------- -----------
  1    Male     52            Clear cell renal cell carcinoma   T1N0M0
  2    Male     52            Clear cell renal cell carcinoma   T1N0M0
  3    Male     60            Clear cell renal cell carcinoma   T3N0M1
  4    Female   54            Clear cell renal cell carcinoma   T2N0M0
  5    Male     61            Clear cell renal cell carcinoma   T2N0M0

**Abbreviation:** TNM, tumor, node, metastasis.

###### 

Identification results of proteins differentially expressed between RCC and the corresponding normal tissues

  Spot no   Protein description                                     Gene name[a](#tfn2-ott-9-1327){ref-type="table-fn"}   Function                  Accession no[b](#tfn2-ott-9-1327){ref-type="table-fn"}   Theoretical[c](#tfn3-ott-9-1327){ref-type="table-fn"} MW/pI   Score[d](#tfn4-ott-9-1327){ref-type="table-fn"}   Coverage[e](#tfn5-ott-9-1327){ref-type="table-fn"}   Fold change[f](#tfn6-ott-9-1327){ref-type="table-fn"}
  --------- ------------------------------------------------------- ----------------------------------------------------- ------------------------- -------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------- ---------------------------------------------------- -------------------------------------------------------
  1         Phosphoenolpyruvate carboxykinase \[GTP\]               *PCK2*                                                Metabolism                Q16822                                                   71,438/7.57                                                   233                                               22%                                                  ↓
  2         78 kDa glucose-regulated protein                        *GRP78*                                               Molecular chaperone       P11021                                                   72,402/5.07                                                   58                                                6%                                                   ↓
  3         Delta-1-pyrroline-5-carboxylate dehydrogenase           *ALDH4A1*                                             Metabolism                P30038                                                   62,137/8.25                                                   224                                               21%                                                  ↓
  4         Alpha-aminoadipic semialdehyde dehydrogenase            *ALDH7A1*                                             Metabolism                P49419                                                   59,020/8.21                                                   255                                               22%                                                  ↓
  5         Glycine amidinotransferase                              *GATM*                                                Metabolism                P50440                                                   48,938/8.26                                                   167                                               42%                                                  ↓
  6         Medium-chain specific acyl-CoA dehydrogenase            *ACADM*                                               Metabolism                P11310                                                   47,015/8.61                                                   302                                               26%                                                  ↓
  7         Argininosuccinate synthase                              *ASS*                                                 Metabolism                P00966                                                   46,786/8.08                                                   230                                               33%                                                  ↓
  8         Fructose-1,6-bisphosphatase 1                           *FBP1*                                                Metabolism                P09467                                                   37,218/6.54                                                   1,094                                             56%                                                  ↓
  9         3-Hydroxyisobutyryl-CoA hydrolase                       *HIBCH*                                               Metabolism                Q6NVY1                                                   43,797/8.38                                                   714                                               44%                                                  ↓
  10        Acetyl-CoA acetyltransferase, mitochondrial             *ACAT1*                                               Metabolism                P24752                                                   45,456/8.98                                                   585                                               39%                                                  ↓
  11        Ester hydrolase C11orf54                                *C11orf54*                                            Metabolism                Q9H0W9                                                   35,608/6.23                                                   240                                               31%                                                  ↓
  12        Glycerol-3-phosphate dehydrogenase \[NAD+\]             *GPD1*                                                Metabolism                P21695                                                   38,171/5.81                                                   863                                               60%                                                  ↓
  13        Complement component 1 Q subcomponent-binding protein   *C1QBP*                                               Immune regulation         P07021                                                   31,749/4.74                                                   2,109                                             46%                                                  ↓
  14        Agmatinase, mitochondrial                               *AGMAT*                                               Metabolism                Q9BSE5                                                   38,206/7.55                                                   707                                               41%                                                  ↓
  15        Calbindin                                               *CALB1*                                               Metabolism                P05937                                                   30,291/4.7                                                    531                                               46%                                                  ↓
  16        Glutathione peroxidase 3                                *GPX3*                                                Metabolism                P22352                                                   25,765/8.26                                                   491                                               29%                                                  ↓
  17        Cytochrome b--c1 complex subunit Rieske                 *UQCRFS1*                                             Electron transport        P47985                                                   29,934/8.55                                                   405                                               37%                                                  ↓
  18        ES1 protein homolog                                     *C21orf33*                                            Metabolism                P30042                                                   28,495/8.5                                                    201                                               38%                                                  ↓
  19        Transgelin                                              *TAGLN*                                               Structural component      P01995                                                   22,653/8.87                                                   158                                               57%                                                  ↓
  20        Nucleoside diphosphate kinase B                         *NME2*                                                Metabolism                P22392                                                   17,401/8.52                                                   205                                               40%                                                  ↓
  21        Nucleoside diphosphate kinase A                         *NME1*                                                Metabolism                P15531                                                   17,309/5.83                                                   246                                               53%                                                  ↓
  22        Peptidyl-prolyl cis--trans isomerase B                  *PPIB*                                                Metabolism                P23284                                                   23,785/9.42                                                   511                                               41%                                                  ↓
  23        Transthyretin                                           *TTR*                                                 Hormone-binding protein   P02766                                                   15,991/5.52                                                   122                                               40%                                                  ↓
  24        Cytochrome c oxidase subunit 5A, mitochondrial          *COX5A*                                               Electron transport        P20674                                                   16,923/6.3                                                    435                                               47%                                                  ↓
  25        Fatty acid-binding protein, liver                       *FABP1*                                               Lipid transport           P07148                                                   14,256/6.6                                                    368                                               53%                                                  ↓
  26        10 kDa heat shock protein                               *HSPE1*                                               Metabolism                P61604                                                   10,925/8.89                                                   533                                               52%                                                  ↓
  27        Serum albumin                                           *ALB*                                                 Metabolism                P02768                                                   71,317/5.92                                                   195                                               16%                                                  ↑
  28        Retinal dehydrogenase 1                                 *ALDH1*                                               Metabolism                P00352                                                   55,454/6.3                                                    1,196                                             59%                                                  ↑
  29        Alpha-enolase                                           *ENO1*                                                Metabolism                Q6GMP2                                                   47,481/7.01                                                   2,799                                             65%                                                  ↑
  30        Glycine amidinotransferase, mitochondrial               *GATM*                                                Metabolism                P50440                                                   48,938/8.26                                                   288                                               49%                                                  ↑
  31        Pyruvate kinase isozymes M1/M2                          *KPYM*                                                Metabolism                Q9BWB5                                                   58,480/7.96                                                   259                                               29%                                                  ↑
  32        Septin-2                                                *SEPT2*                                               Structural component      Q15019                                                   41,689/6.15                                                   519                                               40%                                                  ↑
  33        Fumarylacetoacetase                                     *FAH*                                                 Metabolism                P16930                                                   46,743/6.46                                                   425                                               30%                                                  ↑
  34        Gamma-enolase                                           *ENO2*                                                Metabolism                P09104                                                   47,581/4.91                                                   771                                               7%                                                   ↑
  35        Phosphotriesterase-related protein                      *PTER*                                                Metabolism                Q96BW5                                                   39,506/6.07                                                   201                                               59%                                                  ↑
  36        Alpha-soluble NSF attachment protein                    *NAPA*                                                Electron transport        P54920                                                   33,667/5.23                                                   228                                               66%                                                  ↑
  37        Annexin A4                                              *ANXA4*                                               Calcium ion binding       P09525                                                   36,092/5.84                                                   985                                               54%                                                  ↑
  38        Phosphoserine aminotransferase                          *PSAT1*                                               Metabolism                Q9Y617                                                   40,796/7.56                                                   249                                               44%                                                  ↑
  39        Aldose reductase                                        *ALDR1*                                               Metabolism                P15121                                                   36,230/6.51                                                   293                                               68%                                                  ↑
  40        Annexin A2                                              *ANXA2*                                               Calcium ion binding       P07355                                                   38,808/7.57                                                   359                                               46%                                                  ↑
  41        Proteasome activator complex subunit 2                  *PSME2*                                               Proteolysis               Q9UL46                                                   27,555/5.54                                                   584                                               66%                                                  ↑
  42        Proteasome subunit alpha type-3                         *PSMA3*                                               Proteolysis               P25788                                                   28,643/5.19                                                   224                                               14%                                                  ↑
  43        S-formylglutathione hydrolase                           *ESD*                                                 Metabolism                P10768                                                   31,956/6.54                                                   276                                               47%                                                  ↑
  44        Voltage-dependent anion-selective channel protein 2     *VDAC2*                                               Electron transport        P45880                                                   32,060/7.49                                                   235                                               40%                                                  ↑
  45        Nicotinamide *N*-methyltransferase                      *NNMT*                                                Metabolism                P40261                                                   30,011/5.56                                                   648                                               50%                                                  ↑
  46        Glutathione *S*-transferase P                           *GSTP1*                                               Metabolism                P09211                                                   23,569/5.43                                                   1,197                                             85%                                                  ↑
  47        Proteasome subunit beta type-4                          *PSMB4*                                               Proteolysis               P28070                                                   29,242/5.72                                                   436                                               38%                                                  ↑
  48        Phosphoglycerate mutase 1                               *PGAM1*                                               Metabolism                P18669                                                   28,900/6.67                                                   197                                               45%                                                  ↑
  49        Triosephosphate isomerase                               *TPI*                                                 Metabolism                P60174                                                   26,943/6.45                                                   1,109                                             55%                                                  ↑
  50        Superoxide dismutase \[Mn\]                             *SOD2*                                                Electron transport        P04179                                                   24,722/8.35                                                   442                                               59%                                                  ↑
  51        Proteasome subunit beta type-8                          *PSMB8*                                               Proteolysis               P28062                                                   30,677/7.67                                                   273                                               27%                                                  ↑
  52        Actin, cytoplasmic 1                                    *ACTB*                                                Structural component      P60709                                                   42,052/5.29                                                   194                                               7%                                                   ↑
  53        Alpha-1-antitrypsin                                     *AAT*                                                 Metabolism                P01009                                                   46,878/5.37                                                   44                                                3%                                                   ↑
  54        Sorcin                                                  *SRI*                                                 Calcium ion binding       P30626                                                   21,947/5.32                                                   237                                               47%                                                  ↑
  55        Ferritin heavy chain                                    *FTH1*                                                Metabolism                P02794                                                   21,383/5.3                                                    110                                               22%                                                  ↑
  56        Haptoglobin                                             *HP*                                                  Metabolism                P00738                                                   45,861/6.13                                                   139                                               14%                                                  ↑
  57        Alpha-crystallin B chain                                *CRYAB*                                               Metabolism                P02511                                                   20,146/6.76                                                   772                                               72%                                                  ↑
  58        Hippocalcin-like protein 1                              *HPCAL1*                                              Metabolism                P37235                                                   22,413/5.21                                                   108                                               29%                                                  ↑
  59        Ferritin light chain                                    *FTL*                                                 Metabolism                P02792                                                   20,064/5.51                                                   391                                               41%                                                  ↑
  60        Eukaryotic translation initiation factor 5A-1           *EIF5A*                                               Translation regulation    P63241                                                   17,053/5.08                                                   303                                               42%                                                  ↑
  61        Matrilysin                                              *MMP7*                                                Metabolism                P09237                                                   29,829/7.74                                                   181                                               35%                                                  ↑
  62        Cofilin-1                                               *COF1*                                                Signal transduction       P23528                                                   18,723/8.22                                                   364                                               31%                                                  ↑
  63        Peptidyl-prolyl cis--trans isomerase A                  *PPIA*                                                Protein folding           P62937                                                   18,233/7.68                                                   548                                               64%                                                  ↑
  64        Annexin A3                                              *ANXA3*                                               Calcium ion binding       P12429                                                   36,527/5.63                                                   87                                                4%                                                   ↑
  65        Fatty acid-binding protein, epidermal                   *FABP5*                                               Structural component      Q01469                                                   15,497/6.6                                                    291                                               43%                                                  ↑
  66        Histidine triad nucleotide-binding protein 1            *HINT1*                                               Metabolism                P49773                                                   13,905/6.43                                                   477                                               65%                                                  ↑
  67        Glutathione *S*-transferase theta-1                     *GSTT1*                                               Metabolism                P30711                                                   27,489/7.01                                                   125                                               13%                                                  ↑
  68        Small nuclear ribonucleoprotein F                       *SNRPF*                                               Metabolism                P62306                                                   97,76/4.7                                                     161                                               40%                                                  ↑
  69        SH3 domain-binding glutamic acid-rich-like protein 3    *SH3BGRL3*                                            Metabolism                Q9H299                                                   10,488/4.82                                                   194                                               66%                                                  ↑
  70        Protein S100-A4                                         *S100A4*                                              Calcium ion binding       P26447                                                   11,949/5.85                                                   367                                               49%                                                  ↑
  71        Protein S100-A11                                        *S100A11*                                             Calcium ion binding       P31949                                                   11,847/6.56                                                   1,792                                             73%                                                  ↑
  72        Beta-2-microglobulin                                    *B2M*                                                 Immune regulation         P61769                                                   13,820/6.06                                                   402                                               37%                                                  ↑
  73        Ubiquitin-40S ribosomal protein S27a                    *RPS27A*                                              Metabolism                P62979                                                   18,296/9.68                                                   78                                                24%                                                  ↑

**Notes:**

the proteins gene name and ID from ExPASy database;

theoretical molecular weight (kDa) and pI from the ExPASy database;

probability-based MOWSE scores;

number of unique peptides identified by MS/MS sequencing and sequence coverage;

expression level in RCC compared with the corresponding normal tissues. ↑, increase; ↓, decrease.

**Abbreviations:** MW, molecular weight; pI, isoelectric point; MS, mass spectra; RCC, renal cell carcinoma.

###### 

Enriched processes and pathways identified with the kegg database using proteins

  Pathway                                        Count   Gene                                                                                *P*-value
  ---------------------------------------------- ------- ----------------------------------------------------------------------------------- -----------
  Glycolysis/gluconeogenesis                     9       *ENO1*, *ENO2*, *AKR1A1*, *PGAM1*, *PGAM4*, *TPI1*, *PCK2*, *ALDH7A1*, and *FBP1*   6.86E--16
  Urea cycle and amino metabolism                4       *GATM*, *ALDH7A1*, *ASS1*, and *AGMAT*                                              9.96E--08
  Propanoate metabolism                          4       *ALDH7A1*, *ACADM*, *HIBCH*, and *ACAT1*                                            2.24E--07
  Pyruvate metabolism                            4       *AKR1B1*, *PCK2*, *ALDH7A1*, and *ACAT1*                                            4.85E--07
  Valine, leucine, and isoleucine degradation    4       *ALDH7A1*, *ACADM*, *HIBCH*, and *ACAT1*                                            7.77E--07
  Proteasome                                     4       *PSME2*, *PSMA3*, *PSMB4*, and *PSMB8*                                              9.25E--07
  PPAR signaling pathway                         4       *FABP5*, *PCK2*, *ACADM*, and *FABP1*                                               4.25E--06
  Beta-alanine metabolism                        3       *ALDH7A1*, *ACADM*, and *HIBCH*                                                     5.92E--06
  Arginine and proline metabolism                3       *GATM*, *ALDH4A1*, and *ASS1*                                                       2.35E--05
  Fructose and mannose metabolism                3       *AKR1B1*, *TPI1*, and *FBP1*                                                        2.35E--05
  Fatty acid metabolism                          3       *ALDH7A1*, *ACADM*, and *ACAT1*                                                     4.63E--05
  Glycerolipid metabolism                        3       *AKR1B1*, *AKR1A1*, and *ALDH7A1*                                                   5.28E--05
  Glutathione metabolism                         3       *GSTP1*, *GSTT1*, and *GPX3*                                                        6.36E--05
  Antigen processing and presentation            3       *PSME2*, *B2M*, and *HSPA5*                                                         3.53E--04
  Bile acid biosynthesis                         2       *ALDH7A1* and *SOAT1*                                                               9.10E--04
  Butanoate metabolism                           2       *ALDH7A1* and *ACAT1*                                                               0.001562
  Glycine, serine, and threonine metabolism      2       *GATM* and *PSAT1*                                                                  0.001996
  Tryptophan metabolism                          2       *ALDH7A1* and *ACAT1*                                                               0.001996
  Metabolism of xenobiotics by cytochrome P450   2       *GSTP1* and *GSTT1*                                                                 0.005199
  Drug metabolism -- cytochrome P450             2       *GSTP1* and *GSTT1*                                                                 0.005491
  Pyrimidine metabolism                          2       *NME2* and *NME1*                                                                   0.009003
  Insulin signaling pathway                      2       *PCK2* and *FBP1*                                                                   0.019038
  Oxidative phosphorylation                      2       *UQCRFS1* and *COX5A*                                                               0.019297
  Purine metabolism                              2       *NME2* and *NME1*                                                                   0.022799

**Note:** Enriched processes and pathways identified with the kegg database using proteins which were significantly altered in RCC as compared to normal tissue, with *P*\<0.05.

**Abbreviation:** RCC, renal cell carcinoma.

[^1]: These authors contributed equally to this work
